Evaluation of Genotypic and Phenotypic Methods to Detect Carbapenemase Production in Gram-Negative Bacilli.

BACKGROUND Carbapenemase-producing gram-negative bacteria (CP-GNB) are an urgent and expanding public health threat. Rapid and accurate identification of these organisms facilitates infection prevention efforts in healthcare facilities. The objective of our study was to evaluate methods to detect and identify CP-GNB. METHODS We examined 189 carbapenem-resistant GNB(CR-GNB), including Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii complex, using 3 different methods: 2 methods to screen isolates of GNB for carbapenemase production [the carbapenem inactivation method (CIM) and 2 chromogenic agars] and a molecular method (Cepheid GeneXpert Carba-R) to identify the mechanism of carbapenem resistance and the associated resistance genes (blaKPC, blaNDM, blaIMP, blaOXA-48-like, and blaVIM). RESULTS The CIM was a simple and inexpensive phenotypic screen to differentiate between CR-GNB and CP-GNB, with improved analytical performance characteristics and inter-reader correlation compared to the modified Hodge test. Both chromogenic agars evaluated (HardyCHROM CRE and chromID CARBA) were able to support growth of most of the organisms tested, including isolates possessing the blaOXA-48-like gene. However, these media had a low analytical specificity for carbapenemase production, with breakthrough of CR-GNB that did not produce a carbapenemase. The Xpert Carba-R assay was rapid and easy to perform, and demonstrated 100% positive and negative agreement for characterization of genetic determinants of carbapenem resistance. CONCLUSIONS Screening by CIM followed by the Xpert Carba-R PCR is an accurate method for detecting and characterizing CP-GNB, including Enterobacteriaceae, P. aeruginosa, and A. baumannii complex.

[1]  N. Hasegawa,et al.  Rapid Detection and Typing of Carbapenemase Genes from Carbapenem-Resistant Enterobacteriaceae Isolates Collected in a Japanese Hospital Using the Xpert Carba-R Assay. , 2017, Japanese journal of infectious diseases.

[2]  B. Diederen,et al.  Rapid and accurate detection of carbapenemase genes in Enterobacteriaceae with the Cepheid Xpert Carba-R assay. , 2016, Journal of medical microbiology.

[3]  A. Cortegiani,et al.  Use of Cepheid Xpert Carba-R® for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit , 2016, PloS one.

[4]  Aynur Gulcan,et al.  The identification of carbapenemase types in Enterobacteriaceae by using molecular assay and phenotyping confirmation tests. , 2016, Journal of microbiological methods.

[5]  R. Humphries,et al.  Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs , 2016, Journal of Clinical Microbiology.

[6]  T. Naas,et al.  Improvement of the Xpert Carba-R Kit for the Detection of Carbapenemase-Producing Enterobacteriaceae , 2016, Antimicrobial Agents and Chemotherapy.

[7]  B. Veeraraghavan,et al.  Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat , 2016, Journal of global infectious diseases.

[8]  D. Yong,et al.  Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital , 2015, Annals of laboratory medicine.

[9]  T. W. Boo,et al.  Cross-transmission of Escherichia coli producing OXA-181 in hospitalized patients and failure of carbapenemase detection by commercial and in-house PCR assays. , 2016, Journal of medical microbiology.

[10]  C. Donskey,et al.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods , 2015, Clinical Microbiology Reviews.

[11]  Tse Hsien Koh,et al.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli , 2015, Antimicrobial Agents and Chemotherapy.

[12]  Michael J. Rybak,et al.  The β‐Lactams Strike Back: Ceftazidime‐Avibactam , 2015, Pharmacotherapy.

[13]  B. Veeraraghavan,et al.  Rapid Screening for Carbapenem Resistant Organisms: Current Results and Future Approaches. , 2015, Journal of clinical and diagnostic research : JCDR.

[14]  N. Woodford,et al.  Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria. , 2015, The Journal of antimicrobial chemotherapy.

[15]  Ronald N. Jones,et al.  Ceftazidime-Avibactam Activity Tested against Enterobacteriaceae Isolates from U.S. Hospitals (2011 to 2013) and Characterization of β-Lactamase-Producing Strains , 2015, Antimicrobial Agents and Chemotherapy.

[16]  V. Jarlier,et al.  Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement. , 2015, International journal of antimicrobial agents.

[17]  L. Schouls,et al.  The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative Rods , 2015, PloS one.

[18]  E. Denamur,et al.  Failure to detect carbapenem-resistant Escherichia coli producing OXA-48-like using the Xpert Carba-R assay®. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  D. Sarkis,et al.  How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. , 2014, Journal of microbiological methods.

[20]  C. Burnham,et al.  Comparison of Chromogenic Media for Recovery of Carbapenemase-Producing Enterobacteriaceae (CPE) and Evaluation of CPE Prevalence at a Tertiary Care Academic Medical Center , 2014, Journal of Clinical Microbiology.

[21]  D. Paterson,et al.  Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[22]  P. Nordmann,et al.  Comparative evaluation of a novel chromogenic medium (chromID OXA-48) for detection of OXA-48 producing Enterobacteriaceae. , 2013, Diagnostic microbiology and infectious disease.

[23]  R. Thomson,,et al.  Multiple Broad-Spectrum Beta-Lactamase Targets for Comprehensive Surveillance , 2013, Journal of Clinical Microbiology.

[24]  Michael Bell,et al.  Vital Signs: Carbapenem-Resistant Enterobacteriaceae , 2013, MMWR. Morbidity and mortality weekly report.

[25]  A. Mathers,et al.  Modified Hodge Test versus Indirect Carbapenemase Test: Prospective Evaluation of a Phenotypic Assay for Detection of Klebsiella pneumoniae Carbapenemase (KPC) in Enterobacteriaceae , 2013, Journal of Clinical Microbiology.

[26]  J. Wu,et al.  Characterization of the modified Hodge test-positive isolates of Enterobacteriaceae in Taiwan. , 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[27]  J. Perry,et al.  Comparison of Four Chromogenic Culture Media for Carbapenemase-Producing Enterobacteriaceae , 2012, Journal of Clinical Microbiology.

[28]  V. Miriagou,et al.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  M. Falagas,et al.  Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. , 2011, Future microbiology.

[30]  W. Dunne,et al.  Detection of Klebsiella pneumoniae Carbapenemase (KPC) Production in Non-Klebsiella pneumoniae Enterobacteriaceae Isolates by Use of the Phoenix, Vitek 2, and Disk Diffusion Methods , 2011, Journal of Clinical Microbiology.

[31]  P. Nordmann,et al.  Carbapenemases: molecular diversity and clinical consequences. , 2007, Future microbiology.

[32]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[33]  J. Patel,et al.  Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae , 2007, Journal of Clinical Microbiology.

[34]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[35]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[36]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .